🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Laina D. Mercer

Program for Appropriate Technology in Health

ORCID: 0000-0002-2517-8900

Also affiliated with Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa, Infectious Disease Research Institute, Fred Hutch Cancer Center, Institute for Disease Modeling

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomised, placebo-controlled, phase 1 trial”.

Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomised, placebo-controlled, phase 1 trial

EClinicalMedicine(2022)10.1016/j.eclinm.2022.101323

N/A

1.3DataRank · unranked

55 citations

Viravarn Luvira, Saranath Lawpoolsri, Sant Muangnoicharoen, Supitcha Kamolratanakul, Chaisith Sivakorn +42 more

Immunogenicity and safety of an Escherichia coli-produced bivalent human papillomavirus vaccine (Cecolin) in girls aged 9–14 years in Ghana and Bangladesh: a randomised, controlled, open-label, non-inferiority, phase 3 trial

The Lancet Infectious Diseases(2025)10.1016/s1473-3099(25)00031-3

N/A

0.496DataRank · unranked

10 citations

Anne Schuind, Samuel Adjei, Kalpana Antony, John J. Aponte, Patrick Boakye Yiadom Buabeng +10 more

Safety and Immunogenicity of an Inactivated Recombinant Newcastle Disease Virus Vaccine Expressing SARS-CoV-2 Spike: Interim Results of a Randomised, Placebo-Controlled, Phase 1/2 Trial

medRxiv(2021)10.1101/2021.09.17.21263758

N/A

0.486DataRank · unranked

8 citations

Viravarn Luvira, Saranath Lawpoolsri, Sant Muangnoicharoen, Supitcha Kamolratanakul, Chaisith Sivakorn +41 more

Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: A randomised, comparator-controlled, phase 2 trial

Vaccine(2024)10.1016/j.vaccine.2024.126542

N/A

0.104DataRank · unranked

1 citations

Đặng Đức Anh, Vu Hai Ha, Nguyen Van Thom, Tran Cong Thang, José Mateus +14 more

Safety and Immunogenicity of An Egg-Based Inactivated Newcastle Disease Virus Vaccine Expressing SARS-CoV-2 Spike: Interim Results of a Randomized, Placebo-Controlled, Phase 1/2 Trial in Vietnam

medRxiv(2022)10.1101/2022.02.01.22270253

N/A

0DataRank · unranked

3 citations

Vũ Đình Thiểm, Ha Hai Vu, Van Thanh Ta, Anh Thi Van Pham, Mai Thị Ngọc Đặng +28 more

Baseline malaria infection status and RTS,S/AS01E malaria vaccine efficacy

medRxiv(2023)10.1101/2023.11.22.23298907

N/A

0DataRank · unranked

0 citations

Angela M. Early, Li Li, S. F. Schaffner, Marc Lievens, Akanksha Khorgade +27 more